The German government's global health strategy – a strategy also to support research and development for neglected diseases?

References

• Bundesministerium für Gesundheit. Shaping global health – taking joint action – embracing responsibility. 2014. Available from: http://www.bmg.bund.de/fileadmin/dateien/Publikationen/Gesundheit/Broschueren/Screen_Globale_Gesundheitspolitik_engl.pdf [cited 13 February 2014] The Federal Government's Strategy Paper.
   Google Scholar
• Bozorgmehr K, Bruchhausen W, Hein W, Knipper M, Korte R, Tinnemann P, etal. Germany and global health: an unfinished agenda?. Lancet. 2013; 382: 1702–3.
   Google Scholar
• WHO. Macroeconomics and health: investing in health for economic development. 2011; Geneva, Switzerland: WHO. Report of the Commission on Macroeconomics and Health.
   Google Scholar
• WHO. Public health, innovation and intellectual property rights. 2006; Geneva, Switzerland: WHO. Report of the Commission on Intellectual Property Rights, Innovation and Public Health.
   Google Scholar
• WHO. Closing the gap in a generation. Health equity through action on the social determinants of health. 2008; Geneva, Switzerland: WHO. Final Report. Commission on Social Determinants of Health.
   Google Scholar
• Hoffman SJ, Rottingen JA. Assessing implementation mechanisms for an international agreement on research and development for health products. Bull World Health Organ. 2012; 90: 854–63.
   Google Scholar
• Rottingen JA, Chamas C. A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG). PLoS Med. 2012; 9: e1001219.
   Google Scholar
• Fehr A, Thürmann P, Razum O. Editorial: drug development for neglected diseases: a public health challenge. Trop Med Int Health. 2006; 11: 1335–8.
   Google Scholar
• WHO. Research and development to meet health needs in developing countries: strengthening global financing and coordination. 2012; Geneva, Switzerland: WHO. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination.
   Google Scholar
• Dentico N, Ford N. The courage to change the rules: a proposal for an essential health R&D treaty. PLoS Med. 2005; 2: e14.
   Google Scholar
• CPTech. Medical Research and Development Treaty (MRDT). 2005. Available from: http://www.cptech.org/workingdrafts/rndtreaty4.pdf [cited 14 February 2014] Discussion draft 4.
   Google Scholar
• Orsenigo L. Review of CPTech proposal for an R&D treaty. 2005. Available from: http://www.who.int/intellectualproperty/submissions/orsenigo_comments.pdf [cited 14 February 2014] Submission to the WHO Commission on intellectual property, innovation and public health.
   Google Scholar
• Hubbard T. Reply to the comments requested by CIPIH and WHO to the CPTech proposal for a Medical Research and Development Treaty (MRDT). 2005. Available from: http://www.who.int/intellectualproperty/submissions/SubmissionsHubbard.pdf [cited 13 February 2014].
   Google Scholar
• Farlow A. A Global Medical Research and Development Treaty. 2007. An answer to global health needs? IPN Working Papers on Intellectual Property, Innovation and Health Available from: http://www.andrewfarlow.com/global_medical_research_treaty.pdf [cited 14 February 2014]..
   Google Scholar
• Haffeld JB, Siem H, Rottingen JA. Examining the global health arena: strengths and weaknesses of a convention approach to global health challenges. J Law Med Ethics. 2010; 38: 614–28.
   Google Scholar
• Haffeld J, Heggenhougen HK, Lie SO, Rottingen JA, Schei B. The idea of a convention for global health. Tidsskr Nor Laegeforen. 2011; 131: 1787–90.
   Google Scholar
• Gostin LO, Friedman EA, Ooms G, Gebauer T, Gupta N, Sridhar D, etal. The joint action and learning initiative: towards a global agreement on national and global responsibilities for health. PLoS Med. 2011; 8: e1001031.
   Google Scholar
• Sidibe M, Buse K. A framework convention on global health: a catalyst for justice. Bull World Health Organ. 2012; 90: 870–0A. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Gostin LO, Friedman EA. Towards a Framework Convention on Global Health: a transformative agenda for global health justice. Yale J Health Policy Law Ethics. 2013; 13: 1–75. [PubMed Abstract].
   Google Scholar
• World Health Assembly. Resolution WHA65.22. Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. Sixty-fifth World Health Assembly, Geneva, 21–26 May 2012. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA65-REC1/A65_REC1-en.pdf#page=25 [cited 13 February 2014]..
   Google Scholar
• Rottingen JA, Chamas C, Goyal LC, Harb H, Lagrada L, Mayosi BM. Securing the public good of health research and development for developing countries. Bull World Health Organ. 2012; 90: 398–400.
   Google Scholar
• Rottingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, etal. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?. Lancet. 2013; 382: 1286–307.
   Google Scholar
• Gostin LO, Heywood M, Ooms G, Grover A, Rottingen JA, Chenguang W. National and global responsibilities for health. Bull World Health Organ. 2010; 88: 719–719A.
   Google Scholar
• Costa Chaves G, Oliveira MA. A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement. Bull World Health Organ. 2007; 85: 49–56.
   PubMed Web of Science ®Google Scholar
• BUKO Pharma-Kampagne. Pharmaindustrie erfindet die Zivilgesellschaft neu. 2013. Available from: http://www.bukopharma.de/uploads/file/Presse/pm_20131128_Gruendung_Netzwerk_Tropenkrankheiten_ohneTel.pdf [cited 14 February 2014].
   Google Scholar
• Nationales Aktionsbündnis für Menschen mit seltenen Erkrankungen. Nationaler Aktionsplan für Menschen mit Seltenen Erkrankungen. 2013. Available from: http://www.namse.de/ [cited 13 February 2014] Handlungsfelder, Empfehlungen und Maßnahmenvorschläge.
   Google Scholar
• Fehr A, Thürmann P, Razum O. Expert Delphi survey on research and development into drugs for neglected diseases. BMC Health Serv Res. 2011; 11: 312.
   Google Scholar
• Policy Cures. G-Finder global funding of innovation for neglected diseases. G-Finder Fact Sheet. An emerging leader: Germany's role in neglected and poverty-related disease R&D. 2013. Available from: http://policycures.org/downloads/GF_GermanReport_English.pdf [cited 17 June 2014]..
   Google Scholar